HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Hirudin therapy and blood coagulability].

Abstract
The changes in blood coagulative properties, which occur in the treatment with medical leeches, were studied in 57 patients with coronary heart, rheumatic and chronic pulmonary diseases. Hirudin therapy was established to affect blood coagulation. The leech salina penetrated into the skin wound to block hemostasis. Having entered the circulating blood, some part of the saliva normalized its impaired coagulative properties. The correction of the above abnormalities and related bleeding indicate it beneficial to use hirudin therapy in secondary coagulopathies and circulatory decompensation.
AuthorsG S Isakhanian, K S Tumasian, Z E Barsegian, L S Mkrtchian, A K Karapetian, N G Fldzhian
JournalKardiologiia (Kardiologiia) Vol. 32 Issue 5 Pg. 79-81 (May 1992) ISSN: 0022-9040 [Print] RUSSIA
Vernacular TitleGirudoterapiia i svertyvaemost' krovi.
PMID1405272 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hirudins
Topics
  • Blood Coagulation (drug effects)
  • Cardiovascular Diseases (therapy)
  • Coronary Disease (therapy)
  • Hirudin Therapy
  • Hirudins (pharmacology)
  • Humans
  • Middle Aged
  • Pulmonary Heart Disease (therapy)
  • Rheumatic Heart Disease (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: